← Open Payments lookup

AMY SCHWARTZBURG: Open Payments

NPI 1033220967 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,103 in 37 payments from 8 companies in 2025. Trend: 2023 $599 · 2024 $2,328 · 2025 $6,103

Consulting: $4,284Food & beverage: $1,288Travel & lodging: $531
CompanyPaymentsAmount
GENZYME CORPORATION14$5,445
Amgen Inc.10$260
Novartis Pharmaceuticals Corporation4$117
Alexion Pharmaceuticals, Inc.2$93
TG Therapeutics, Inc.3$70
Genentech, Inc.2$51
ABBVIE INC.1$35
Genentech USA, Inc.1$32

Products named: UPLIZNA, KESIMPTA, BRIUMVI, Ocrevus Zunovo, ULTOMIRIS, BOTOX.

Industry payments across CA — which companies pay providers there.